Added to YB: 2026-10-14
Pitch date: 2026-10-10
SYK [bullish]
Stryker Corporation
+5.74%
current return
Author Info
Rijnberk InvestInsights shares market-leading companies and top investment ideas through concise, high-conviction analysis. Sign up for the newsletter.
Company Info
Stryker Corporation operates as a medical technology company in the United States and internationally.
Market Cap
$106.4B
Pitch Price
$277.30
Price Target
414.00 (+41%)
Dividend
1.27%
EV/EBITDA
15.60
P/E
28.74
EV/Sales
4.58
Sector
Health Care Equipment and Supplies
Category
value
Stryker Corp. – The Cheapest It Has Been Since 2016, for All the Wrong Reasons.
SYK: Stryker’s 22% sell-off overreacts to temporary vascular supply constraints and softer joint-replacement demand, while Q2 still delivered 9% organic growth, 170 bps of operating-margin expansion and 18% EPS growth. At $277, shares trade at 18.5x 2026 earnings versus a 25x 10-year median; a conservative 22x 2028 EPS supports a $414 target and ~15.5% annualized return including dividends, though delayed vascular recovery could prolong share losses.
Read full article (12 min)